Cranebio

Tokyo, Japan

Cranebio is a biotechnology company that develops healthcare solutions such as self-testing kits for easy and accessible health monitoring.

$1.7M raised

Oct 2023

Series A

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Cranebio raised?

Cranebio has raised $1.7M in total funding. The most recent round was Series A. The last funding was announced in October 2023.

Who are Cranebio's investors?

Cranebio's investors include Nippon Venture Capital, Axil Capital, Akigin Capital Partners.

Where is Cranebio headquartered?

Cranebio is headquartered in Tokyo, Japan.

What does Cranebio do?

Cranebio is a biotechnology company that develops healthcare solutions such as self-testing kits for easy and accessible health monitoring.

What stage is Cranebio at?

Cranebio is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 4, 2023.

MLA

"Cranebio — Funding & Investors." VCBacked, October 4, 2023, https://www.vcbacked.co/company/cranebio. Accessed July 3, 2026.

APA

VCBacked. (2023). Cranebio — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/cranebio

Wikipedia (cite web)

{{cite web |title=Cranebio — Funding & Investors |url=https://www.vcbacked.co/company/cranebio |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 4, 2023.